Aurora Cannabis Inc. (NASDAQ:ACB - Get Free Report) was the target of a large growth in short interest in October. As of October 31st, there was short interest totalling 2,810,000 shares, a growth of 6.8% from the October 15th total of 2,630,000 shares. Based on an average daily trading volume, of 1,030,000 shares, the short-interest ratio is presently 2.7 days. Approximately 5.2% of the shares of the stock are sold short.
Hedge funds have recently bought and sold shares of the business. Virtu Financial LLC bought a new stake in shares of Aurora Cannabis in the 1st quarter worth about $727,000. Headlands Technologies LLC raised its position in Aurora Cannabis by 98.8% during the second quarter. Headlands Technologies LLC now owns 74,988 shares of the company's stock valued at $346,000 after purchasing an additional 37,269 shares during the period. TD Asset Management Inc purchased a new stake in Aurora Cannabis during the second quarter valued at approximately $255,000. Mackenzie Financial Corp bought a new stake in shares of Aurora Cannabis in the 2nd quarter valued at approximately $113,000. Finally, Baader Bank Aktiengesellschaft boosted its holdings in shares of Aurora Cannabis by 121.1% in the 2nd quarter. Baader Bank Aktiengesellschaft now owns 22,789 shares of the company's stock worth $100,000 after purchasing an additional 12,481 shares during the period. Hedge funds and other institutional investors own 47.63% of the company's stock.
Aurora Cannabis stock opened at $4.20 on Friday. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.83 and a quick ratio of 1.88. The firm's 50 day moving average price is $5.52 and its 200-day moving average price is $5.88. Aurora Cannabis has a 1 year low of $2.84 and a 1 year high of $9.35. The stock has a market cap of $230.33 million, a P/E ratio of -5.53 and a beta of 1.87.
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.